{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:18:05Z","timestamp":1787807885430,"version":"build-2784847793"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Thyroid hemiagenesis (THA) is a relatively rare disorder in which one thyroid lobe fails to develop. Although most individuals remain clinically euthyroid, they typically exhibit higher thyrotropin (TSH) concentrations than those with a bilobed thyroid gland, possibly reflecting reduced thyroidal reserve and a chronic compensatory response by pituitary thyrotrophs. While pituitary hyperplasia has been reported in the setting of hypothyroidism in THA, a TSH-secreting pituitary neuroendocrine tumor (thyrotropinoma) has not previously been described in this condition. A 30-year-old woman underwent thyroid function testing during the first trimester of her first pregnancy, which revealed a TSH concentration of 2.57 mIU\/L. In accordance with local clinical practice, thyroid ultrasonography was performed and demonstrated absence of the left thyroid lobe, consistent with THA. Given the TSH level &amp;gt;2.5 mIU\/L and the potentially limited thyroidal functional reserve associated with THA, subclinical hypothyroidism was diagnosed. To prevent the development of overt hypothyroidism during pregnancy and its associated maternal and fetal complications, levothyroxine therapy was initiated. Over the following years, levothyroxine was progressively uptitrated, but despite development of clinical features of thyrotoxicosis, with raised free thyroid hormone levels, serum TSH remained unsuppressed, prompting evaluation for this discordant thyroid function pattern. Pituitary MRI demonstrated an 11mm macroadenoma. Further investigations revealed an elevated alpha-glycoprotein subunit (\u03b1-GSU) level and an attenuated TSH response to TRH stimulation. A trial of a depot somatostatin receptor ligand resulted in a marked reduction in thyroid hormone levels. Together, these findings supported the diagnosis of a thyrotropinoma. Transsphenoidal surgery was performed, and histology confirmed a PIT1 lineage plurihormonal tumor with predominant TSH expression. Following surgery, the patient developed central hypothyroidism and was recommenced on levothyroxine therapy. We report the first documented case of a pituitary adenoma in a patient with THA; notably, the lesion was the rarest pituitary tumor subtype, a thyrotropinoma. This observation raises the possibility of a biological link driven by chronic thyrotroph stimulation, potentially contributing to adenoma formation. A similar feedback-driven mechanism has been proposed to explain cases of coexistence of resistance to thyroid hormone \u03b2 (RTH\u03b2) and thyrotropinoma. Therefore, in patients with THA receiving levothyroxine therapy, the development of hyperthyroxinaemia with a non-suppressed TSH should prompt consideration of a thyrotropinoma.<\/jats:p>","DOI":"10.3389\/fendo.2026.1902011","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:27:23Z","timestamp":1787804843000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Development of a thyrotropinoma in a patient with thyroid hemiagenesis"],"prefix":"10.3389","volume":"17","author":[{"given":"Emil Bartosz","family":"Rozenek","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Centre of Postgraduate Medical Education","place":["Warsaw, Poland"]},{"name":"Doctoral School of Translational Medicine, Centre of Postgraduate Medical Education","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gurnell","sequence":"additional","affiliation":[{"name":"Cambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Institute of Metabolic Science, University of Cambridge, and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke\u2019s Hospital","place":["Cambridge, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Kunicki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Maria Sklodowska-Curie National Research Institute of Oncology","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Maksymowicz","sequence":"additional","affiliation":[{"name":"Department of Cancer Pathomorphology, Maria Sklodowska-Curie National Research Institute of Oncology","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Korbonits","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Barts and The London School of Medicine, Queen Mary University of London, Charterhouse Square","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Zgliczy\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Centre of Postgraduate Medical Education","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Stelmachowska-Bana\u015b","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Centre of Postgraduate Medical Education","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1999.9.1075","article-title":"Thyroid hemiagenesis in an endemic goiter area diagnosed by ultrasonography: Report of sixteen patients","volume":"9","author":"Mikosch","year":"1999","journal-title":"Thyroid"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-00784","article-title":"Thyroid hemiagenesis: Incidence, clinical significance, and genetic background","volume":"102","author":"Szczepanek-Parulska","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0590","article-title":"Increased risk of thyroid pathology in patients with thyroid hemiagenesis: Results of a large cohort case\u2013control study","volume":"162","author":"Ruchala","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021574","article-title":"Thyroid hemiagenesis: Prevalence in normal children and effect on thyroid function","volume":"88","author":"Maiorana","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO classification of pituitary tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr Pathol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad681","article-title":"Approach to the patient with raised thyroid hormones and nonsuppressed TSH","volume":"109","author":"Moran","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01066-x","article-title":"A 2019 update on TSH-secreting pituitary adenomas","volume":"42","author":"Beck-Peccoz","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-0863-3","article-title":"Thyrotropin-secreting pituitary adenomas: Epidemiology, diagnosis, and management","volume":"52","author":"Amlashi","year":"2016","journal-title":"Endocrine"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0162","article-title":"Endocrine tumours: Thyrotropin-secreting pituitary adenoma: A structured review of 535 adult cases","volume":"185","author":"De Herdt","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1159\/000453061","article-title":"Reference values for TSH and free thyroid hormones in healthy pregnant women in Poland: A prospective, multicenter study","volume":"6","author":"Kostecka-Matyja","year":"2017","journal-title":"Eur Thyroid J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.5603\/EP.a2021.0089","article-title":"Thyroid diseases in pregnancy: Guidelines of the Polish Society of Endocrinology [Choroby tarczycy w ci\u0105\u017cy: zalecenia post\u0119powania Polskiego Towarzystwa Endokrynologicznego","volume":"72","author":"Hubalewska-Dydejczyk","year":"2021","journal-title":"Endokrynologia Polska"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-24-0125","article-title":"2024 European Thyroid Association guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action","volume":"13","author":"Persani","year":"2024","journal-title":"Eur Thyroid J"},{"key":"B13","unstructured":"Thyrotropin-secreting pituitary adenomas\n          \n          \n            \n              Persani\n              L\n            \n            \n              Lania\n              A\n            \n            \n              Beck-Peccoz\n              P\n            \n          \n          MDText.com, Inc\n          Endotext [Internet]\n          \n          2025"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02192.x","article-title":"Different responses to chronic somatostatin analogues in patients with central hyperthyroidism","volume":"62","author":"Mannavola","year":"2005","journal-title":"Clin Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.2.5505","article-title":"Thyrotropin-secreting pituitary tumors: Diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health","volume":"84","author":"Brucker-Davis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3171\/2020.1.JNS192787","article-title":"Immediate postoperative measurement of thyroid-stimulating hormone as an early predictor of remission in thyroid-stimulating hormone\u2013secreting pituitary adenomas","volume":"134","author":"Kim","year":"2021","journal-title":"J Neurosurg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/BF03351023","article-title":"Thyroid hemiagenesis in two sisters","volume":"7","author":"Rajmil","year":"1984","journal-title":"J Endocrinol Invest"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1976.03630090040010","article-title":"Secondary pituitary insufficiency: Report of three cases of ectopia or hemiagenesis of the thyroid gland","volume":"136","author":"Leiba","year":"1976","journal-title":"Arch Internal Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-17-6-610","article-title":"Thyrotropin-secreting pituitary tumors*","volume":"17","author":"Beck-Peccoz","year":"1996","journal-title":"Endocr Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12061368","article-title":"Pituitary hyperplasia due to longstanding primary hypothyroidism: A case report and comprehensive review of the literature","volume":"12","author":"Roux","year":"2024","journal-title":"Biomedicines"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0b013e32835f45c5","article-title":"Precursor lesions of endocrine system neoplasms","volume":"45","author":"Mete","year":"2013","journal-title":"Pathology"},{"key":"B22","unstructured":"Pituitary gland in hypothyroidism. Histologic and immunocytologic study\n          \n          \n            \n              Scheithauer\n              BW\n            \n            \n              K\n              K\n            \n            \n              Rv\n              R\n            \n            \n              N\n              R\n            \n          \n          \n          1985"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0016-8","article-title":"Epidemiology and biomarker profile of pituitary adenohypophysial tumors","volume":"31","author":"Mete","year":"2018","journal-title":"Mod Pathol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1530\/EDM-18-0083","article-title":"Emergence of a latent TSHoma pituitary macroadenoma on a background of primary autoimmune hypothyroidism","volume":"2018","author":"Yap","year":"2018","journal-title":"Endocrinology Diabetes Metab Case Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12902-023-01357-8","article-title":"Coexistence of TSH-secreting adenoma and primary hypothyroidism: A case report and review of literature","volume":"23","author":"Ren","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2020.1803304","article-title":"Pituitary hyperplasia mimicking thyrotropin-producing pituitary adenoma in the patient with resistance to thyroid hormone: A case report","volume":"132","author":"Suntornlohanakul","year":"2021","journal-title":"Int J Neurosci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1998.8.679","article-title":"Reversible pituitary enlargement in the syndrome of resistance to thyroid hormone","volume":"8","author":"Gurnell","year":"1998","journal-title":"Thyroid"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3994","article-title":"A patient with a thyrotropin-secreting microadenoma and resistance to thyroid hormone (P453T)","volume":"100","author":"Teng","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1131044","article-title":"The clinical characteristics and gene mutations associated with thyroid hormone resistance syndrome coexisting with pituitary tumors","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.1.124-135.2005","article-title":"An unliganded thyroid hormone \u03b2 receptor activates the cyclin D1\/cyclin-dependent kinase\/retinoblastoma\/E2F pathway and induces pituitary tumorigenesis","volume":"25","author":"Furumoto","year":"2005","journal-title":"Mol Cell Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.aed.2025.09.015","article-title":"Coexistence of resistance to thyroid hormone and a thyroid stimulating hormone-secreting pituitary adenoma","volume":"13","author":"Koo","year":"2026","journal-title":"AACE Endocrinol Diabetes"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.76.4.8473377","article-title":"Thyrotropin-producing microadenoma associated with pituitary resistance to thyroid hormone","volume":"76","author":"Watanabe","year":"1993","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1902011\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:27:23Z","timestamp":1787804843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1902011\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":32,"alternative-id":["10.3389\/fendo.2026.1902011"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1902011","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"article-number":"1902011"}}